With a virtual site, clinical trial sponsors and research organizations can expand access and accelerate recruitment by allowing patients to participate from anywhere, regardless of location.
Through the Direct-to-Patient Site, Science 37 brings together our board-certified telemedicine investigators, in-house mobile healthcare nurses, and clinical research coordinators to support patients remotely—as a virtual site—all powered by a unified platform, enabling high-quality data capture and protocol compliance.
Our virtual approach presents many advantages, including:
Download the playbook to learn how a virtual site can transform your neurology clinical trial, and read real case study examples of the Direct-to-Patient Site in action.
Authors
David Kudrow, MD, Medical Director of Neurology, Medical Affairs, Science 37
Jonathan Cotliar, MD, Chief Medical Officer, Science 37